# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k061751   
B. Purpose for Submission: New device   
C. Measurand: Urinary/Cerebrospinal Fluid Protein   
D. Type of Test: Calibrator materials   
E. Applicant: Dade Behring Inc.

# F. Proprietary and Established Names:

Dimension VistaTM System Urinary/Celebrospinal Fluid Protein Calibrator (UCFP CAL – KC260)

G. Regulatory Information:   

<table><tr><td>Product Code</td><td>Classification</td><td>Regulation Section</td><td>Panel</td></tr><tr><td>Calibrator,</td><td>Class II</td><td>21 CFR 862.1150</td><td>75 Clinical</td></tr><tr><td>secondary (JIT)</td><td></td><td>Calibrator</td><td>Chemistry (CH)</td></tr></table>

# H. Intended Use:

1. Intended use(s):

The UCFP CAL is an in vitro diagnostic product for the calibration of the Urinary/Cerebrospinal Fluid Protein (UCFP) method on the Dimension Vista™ System.

2. Indication(s) for use: See Intended use above.

3. Special conditions for use statement(s): Prescription use only

4. Special instrument requirements: Dimension Vista System

# I. Device Description:

The UCFP CAL is an aqueous product containing dilute human serum. The kit consists of three vials of Calibrator A. The volume per vial is $1 . 5 \mathrm { m L }$ . UCFP CAL is ready for use, where no preparation is required. System water is used as the UCFP zero calibrator (Level 1) for the Dimension Vista™ System.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Dimension $\textsuperscript { \textregistered }$ Urinary/Cerebrospinal Fluid Protein Calibrator

2. Predicate K number(s): k934843

3. Comparsion with predicate:

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Dimension VistaTM SystemUrinary/Celebrospinal Fluid ProteinCalibrator</td><td rowspan=1 colspan=1>Dimension® Urinary/Cerebrospinal FluidProtein Calibrator</td></tr><tr><td rowspan=1 colspan=1>IntendedUse</td><td rowspan=1 colspan=1>The UCFP CAL is an in vitro diagnosticproduct for the calibration of theUrinary/Cerebrospinal Fluid Protein(UCFP) method on the DimensionVista™ System.</td><td rowspan=1 colspan=1>Dimension® Urinary/Cerebrospinal FluidProtein Calibrator is an in vitro diagnosticproduct to be used to calibrate theDimension® clinical chemistry system for theUrinary/Cerebrospinal Fluid Protein (UCFP)method.</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>Urinary/Cerebrospinal Fluid Protein</td><td rowspan=1 colspan=1>Urinary/Cerebrospinal Fluid Protein</td></tr><tr><td rowspan=1 colspan=1>Form</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Liquid</td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>NIST SRM 927(1)</td><td rowspan=1 colspan=1>NIST SRM 927(1)</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Aqueous product containing dilutehuman serum</td><td rowspan=1 colspan=1>Saline solution containing human serumalbumin and IgG</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>One level (level 2). Level 1 is systemwater</td><td rowspan=1 colspan=1>Five levels</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

<table><tr><td>STANDARDS</td></tr><tr><td>Title and Reference Number</td></tr><tr><td>Stability Testing of In Vitro Diagnostic Reagents (13640)</td></tr><tr><td>Medical devices - Application of risk management to medical devices (14971:2000)</td></tr></table>

<table><tr><td>Other Standards</td></tr><tr><td></td></tr></table>

<table><tr><td rowspan=1 colspan=4>GUIDANCE</td></tr><tr><td rowspan=1 colspan=1>Document Title</td><td rowspan=1 colspan=1>Office</td><td rowspan=1 colspan=1>Office Division</td><td rowspan=1 colspan=1>Web Page</td></tr><tr><td rowspan=1 colspan=1>Guidance for Industry -Abbreviated 510(k) Submissionsfor In Vitro DiagnosticCalibrators; Final</td><td rowspan=1 colspan=1>OIVD</td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>http://www.fda.gov/cdrh/ode/calibrator.html</td></tr><tr><td rowspan=2 colspan=1>Guidance for Industry and FDAStaff - Use of Symbols on Labelsand in Labeling of In VitroDiagnostic Devices Intended forProfessional Use</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=1 colspan=1>http://www.fda.gov/cdrh/ocd/guidance/4444.html</td></tr><tr><td rowspan=1 colspan=1></td></tr></table>

L. Test Principle: Not applicable

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility: Not Applicable

b. Linearity/assay reportable range: Not Applicable

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

# Tracebility:

The assigned values of the Urinary/Cerebrospinal Fluid Protein Calibrator are traceable to the National Institute of Standards and Technology- Standard Reference Material 927.

# Stability:

Target shelf life for the Dimension Vista™ System Urinary/Cerebrospinal Fluid Protein Calibrator is 12 months. Calibrator shelf life is determined by comparing results of the product stored at $4 \mathrm { { } ^ { \circ } C }$ with control stored at $- 2 0 ^ { \circ } \mathrm { C }$ . The method is calibrated from this stored material. The $4 \mathrm { { } ^ { \circ } C }$ material values are recovered versus the calibration. Recovery versus time is monitored and percent change over time is determined. Percent change should be less than or equal to $3 \%$ . Shelf-life stability (expiration) dating assignment at commercialization reflects the real-time data on file at Dade Behring, Inc. A vial punctured by the instrument and stored on board is stable for seven days. An open vial not stored on board of the instrument, but recapped and stored in a refrigerator is stable for 31 days. For testing, vials are opened /punctured on day zero. A quantity sufficient for multiple calibrations is removed and the vials are recapped and stored at $2 - 8 { } ^ { \circ } \mathrm { C }$ . Opened/punctured vials are tested on days 8, 15, 22, and 32 versus freshly opened vials.

# Value Assignment:

The purified human IgG and human serum albumin are added gravimetrically to stock solution at target concentrations and verified using an instrument calibrated with Master Pool assigned values. Calculated quantities of human serum stock solution are added to base matrix (aqueous solution) in appropriate concentrations for one calibrator level. The test calibrator level is verified using an instrument calibrated with the Master Pool assigned values. The final bottle assignment for test calibrator level of the commercial lot is tested $\Nu = 9 0$ replicates, with multiple reagent lots on multiple instruments.

d. Detection limit: Not applicable   
e. Analytical specificity: Not applicable   
f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Not applicable

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: Not applicable

N. Proposed Labeling: The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.